Prunus africana — Pygeum Bark

The African plum tree whose bark has become one of the most clinically validated natural allies for prostate health — and one of the most urgently conservation-dependent botanicals on Earth.

Botanical Identification

Species: Prunus africana (Hook.f.) Kalkman
Family: Rosaceae
Common Names: Pygeum, African cherry, African plum, red stinkwood, mueri (Kikuyu), kirah (Amharic)
Parts Used: Dried stem bark
Native Range: Montane forests of sub-Saharan Africa, from Cameroon and Kenya to Madagascar, typically at elevations of 1,500–3,000 meters
CITES Status: Appendix II — international trade is regulated and requires export permits to prevent overexploitation. Wild populations have declined significantly due to decades of unsustainable bark harvesting.

Cultural and Historical Use

In the highland communities of East and Central Africa, Prunus africana bark has been used for generations as a remedy for urinary complaints, chest pain, fever, and stomach ailments. Among the Kikuyu of Kenya, a bark decoction known as mueri was traditionally prepared to ease difficult urination in older men — a use that aligns remarkably with its modern clinical applications.

European interest surged in the 1960s when French researchers began studying bark extracts, leading to the development of standardized pharmaceutical preparations widely prescribed across Europe for benign prostatic hyperplasia (BPH). By the 1990s, Pygeum had become one of the most commercially harvested medicinal trees in Africa, prompting its listing under CITES in 1995 to curb unsustainable wildcrafting.

Key Bioactive Compounds

How It Works in the Body

Pygeum bark extract operates through multiple complementary mechanisms that collectively address the pathology of benign prostatic hyperplasia. The phytosterols — particularly beta-sitosterol — compete with inflammatory prostaglandins in prostatic tissue, reducing the swelling and congestion that cause urinary obstruction. Ursolic and oleanolic acid contribute additional anti-inflammatory and anti-edema effects.

The ferulic acid esters serve a distinct role: they reduce levels of prolactin, a hormone that increases the uptake of testosterone into the prostate, and they inhibit cholesterol from accumulating in prostatic tissue — cholesterol being a precursor for local androgen production. Together, these actions slow the hormonal cascade that drives prostate enlargement.

Unlike synthetic 5-alpha-reductase inhibitors, Pygeum does not directly block testosterone conversion to DHT. Instead, it modulates the inflammatory and proliferative environment of the prostate, which may explain its favorable side-effect profile in clinical trials.

Dose Guidelines

Preparation and Uses

• Decoction: Because the active compounds include fat-soluble triterpenes and sterols, a slow simmer of 15–20 minutes is recommended over a simple infusion. Adding a small amount of fat (coconut oil, whole milk) to the brew may enhance extraction of lipophilic compounds.
• Tincture: A higher-proof alcohol (at least 45%) is preferable for capturing the full spectrum of active constituents.
• Capsules: Powdered bark in capsules offers convenience, though standardized extracts remain the most clinically supported form.
• Combination Formulas: Pygeum is frequently combined with saw palmetto (Serenoa repens) and nettle root (Urtica dioica) in prostate support blends, as these herbs target complementary mechanisms.

Optimal Context for Use

• Men experiencing early signs of BPH — frequent urination, weak stream, nighttime waking to urinate
• As a long-term supportive botanical alongside conventional prostate care (with practitioner guidance)
• In combination formulas with saw palmetto and nettle root for a multi-targeted approach
• Allow a minimum of 6–8 weeks of consistent use before evaluating results; most clinical trials ran 60 days or longer

Sustainability and Ethical Harvesting

This is among the most critical sustainability concerns in the herbal trade. Prunus africana is listed on CITES Appendix II, meaning all international trade requires documentation that the bark was harvested sustainably. Decades of destructive whole-tree debarking and illegal logging have devastated wild populations, particularly in Cameroon, the Democratic Republic of Congo, and Madagascar.

Sustainable harvesting protocols call for removing no more than two opposite quarters of bark from mature trees, allowing the remaining bark to regenerate over 4–5 years. Plantation cultivation programs exist in Kenya, Cameroon, and Ethiopia, but demand still outpaces sustainable supply. When purchasing Pygeum bark, verify that your supplier can document legal sourcing with valid CITES permits. Choosing plantation-grown material when available is the most responsible option.

Safety and Cautions

• Generally well-tolerated in clinical trials, with mild gastrointestinal discomfort being the most commonly reported side effect.
• Not appropriate for self-treatment of urinary symptoms without proper diagnosis — prostate cancer, urinary infections, and other conditions can mimic BPH.
• No established safety data for use in women who are pregnant or breastfeeding.
• May theoretically interact with hormonal therapies; consult a healthcare provider if taking finasteride, dutasteride, or hormone-modulating medications.
• Those with known allergies to Rosaceae family plants (cherries, plums, almonds) should exercise caution.

References

• Ishani, A., et al. "Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis." American Journal of Medicine, 109(8), 2000, pp. 654–664.
• Wilt, T., et al. "Pygeum africanum for benign prostatic hyperplasia." Cochrane Database of Systematic Reviews, 2002(1).
• Stewart, K. M. "The African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal tree?" Journal of Ethnopharmacology, 89(1), 2003, pp. 3–13.
• Cunningham, A. B., et al. "Sustainable trade and management of Prunus africana bark." CITES/TRAFFIC Report, 2016.
• European Medicines Agency. "Assessment report on Prunus africana (Hook.f.) Kalkman, cortex." EMA/HMPC, 2016.

Final Note: Pygeum bark represents both the promise and the peril of the global herbal trade. Its clinical record for prostate health is among the strongest of any botanical — yet that very demand has pushed wild populations toward crisis. Every purchase of this bark carries a responsibility to ensure it was sourced legally and sustainably. Used wisely and sourced ethically, Pygeum is a powerful tool in the natural management of prostate health. This product is sold as a botanical specimen for educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.